Nigeria study aims to boost lifesaving sickle cell drug use from 1% to many more
NCT ID NCT06318143
First seen May 22, 2026 · Last updated May 22, 2026
Summary
This study tests a program to help doctors and clinics in Nigeria prescribe hydroxyurea, a medicine that reduces pain and complications from sickle cell disease. Currently, less than 1% of patients in Africa use it, even though it works. The study will enroll 900 patients and train healthcare workers to screen, start, and maintain patients on hydroxyurea over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
University Of Abuja Teaching Hospital
RECRUITINGAbuja, Nigeria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.